muraloncology.com (MURA): Narxning prognoz qilingan daromadga nisbati

Mural Oncology (MURA) tovar belgisi

Mural Oncology plc (MURA) mustahkam likvidlik zaxirasi asosida saraton immunoterapiyasini ishlab chiqmoqda, bu esa prognoz qilingan P/S koeffitsiyenti bilan ta'minlangan. ning joriy qiymati klinik sinovlarda yetakchilik uchun sog'liqni saqlash gigantlari bilan olib borilayotgan shiddatli kurash fonida ushbu metrikaning muvozanatini aks ettiradi. Biznesning muvaffaqiyati yangi molekulalarning sinov natijalariga va tijoratdan oldingi davrda xarajatlarning qat'iy nazorat qilinishiga bog'liq.

Mural Oncology PLC - MURA Forvard P/S multiplikatori (davr: 04.07.2022 - 15.11.2026)

Mural Oncology PLC (MURA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning dastlabki tahlili:MURA (Mural Oncology PLC)
Mural Oncology tomonidan chiqariladigan mahsulotlar

Mural Oncology plc (MURA) kompaniyasining investitsiya jozibadorligi uning noyob patentlangan immunoterapiya molekulalaridan kelib chiqadigan narx belgilash imkoniyatiga asoslangan. Ushbu ko'rsatkich biznesning joriy bozor qiymatini kutilayotgan kelajakdagi savdo hajmlari bilan solishtiradi, bu esa prognoz qilingan bozor kapitallashuvi va daromad nisbatiga aktivning haddan tashqari qimmat baholanganini yoki uzoq muddatli pozitsiyalar uchun fundamental xavfsiz boshpana marginiga ega ekanligini aniqlash imkonini beradi.

Mural Oncology plc raqobatchilari tahlili

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|Champions Oncology, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati XBiotech Inc XBIT|CVM: Forvard P/S multiplikatori|OSTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Radiopharm Theranostics Limited|Forvard P/S multiplikatori artivabio.com|Forvard narx/daromad multiplikatori ANL (Adlai Nortye Limited)|Veru - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Tempest Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati xiliotx.com (XLO)|Renovaro - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori